| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 04/06/2005 | EP1519938A2 Synthesis of purine derivatives |
| 04/06/2005 | CN1195745C Antiviral macrocyclic compounds |
| 04/06/2005 | CN1195526C Medicinal products containing antimer pure beta-D-dioxypentacyclic nucleoside |
| 03/31/2005 | WO2005028479A2 Hiv replication inhibiting purine derivatives |
| 03/31/2005 | WO2005028467A1 Antibacterial 3,5-diaminopiperidine-substitute aromatic and heteroaromatic compounds |
| 03/31/2005 | WO2005028434A2 Novel heterocyclic compounds as hsp90-inhibitors |
| 03/31/2005 | WO2004094449A8 Macrolide-conjugates with anti-inflammatory activity |
| 03/31/2005 | US20050070711 Method for reducing residual alcohols in crystalline valacyclovir hydrochloride |
| 03/31/2005 | US20050070534 Non-peptidic NPY Y2 receptor inhibitors |
| 03/31/2005 | CA2539548A1 Novel heterocyclic compounds as hsp90-inhibitors |
| 03/30/2005 | EP1518854A1 Substituted 06- benzylguanines and 7- or 9- substituted 8-aza-06-benzylguanines |
| 03/30/2005 | EP1518553A2 Use of nitrate ester compounds for treating pain or providing analgesia |
| 03/30/2005 | EP1517908A2 Novel benzimidazole derivatives |
| 03/29/2005 | US6872714 Methods to modulate conditions mediated by the CXCR4 receptor |
| 03/29/2005 | CA2173505C Use of penciclovir for the treatment of post-herpetic neuralgia |
| 03/24/2005 | WO2005026167A1 Process for preparing famciclovir |
| 03/24/2005 | WO2005026153A1 Quinazoline-2, 4-diones as antibacterial agents |
| 03/24/2005 | WO2005025579A1 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators |
| 03/24/2005 | WO2005009348A3 Substituted purine derivatives |
| 03/24/2005 | WO2004110379A3 A1 adenosine receptor antagonists |
| 03/24/2005 | WO2004088312A3 Fluorescently tagged ligands |
| 03/24/2005 | WO2004085421A3 Bioreductively-activated prodrugs |
| 03/24/2005 | US20050065341 Substituted 8-heteroaryl xanthines |
| 03/24/2005 | US20050065335 inhibiting complexation of intercalating molecules with polynucleotides; using modified xanthine molecules as a binding agent; drug delivery system for compounds that have low solubility in aqueous media, including anti-neoplastic agents |
| 03/24/2005 | US20050065171 Therapy, prevention leukemia; antitumor agents |
| 03/24/2005 | CA2788502A1 Non-peptide agonists and antagonists of adrenomedullin and gastric releasing peptide |
| 03/24/2005 | CA2537663A1 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators |
| 03/23/2005 | EP1515972A1 Amide substituted xanthine derivatives with gluconeogenesis modulating activity |
| 03/23/2005 | EP1515971A2 Carbocyclic nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 03/23/2005 | EP1515970A1 Alkynylpurine compounds and production methods thereof |
| 03/23/2005 | EP1381392A4 Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same |
| 03/22/2005 | US6870053 Useful in treatment or prophylaxis of viral infections, for example, human immunodeficiency virus and hepatitis B virus |
| 03/22/2005 | US6870021 Mixtures of condensation polymers comprising organonitrogen or organosulfur polymers and curing agents, having preferential binding, used for analysis, separation and resolution of racemic mixtures |
| 03/22/2005 | US6869974 Pharmaceutical compounds |
| 03/22/2005 | US6869947 Heterocyclic compounds that are inhibitors of the enzyme DPP-IV |
| 03/17/2005 | WO2005023811A1 Process for the preparation of (1s, 4r) -cis-4-‘2-amino-6chloro-9h-purin-9-yl!-2-cyclopentene-1-methanol |
| 03/17/2005 | WO2004074270B1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 03/17/2005 | US20050059684 stabilization against formation of N'-formylvalacyclovir upon storage at elevated humidity, by contacting with humid gases such as air |
| 03/17/2005 | US20050059650 1H-pyrazolo[3,4-d]pyrimidine derivatives as antidiabetic and antiobesity agent |
| 03/17/2005 | DE10335061A1 Verfahren zur Herstellung von OH-geschützten [4-(2,6-damino-9H-purin-9-yl)-1,3-dioxolan-2-yl]methanol-Derivaten Process for preparing OH-protected [4- (2,6-Damino-9H-purin-9-yl) -1,3-dioxolan-2-yl] methanol derivatives |
| 03/16/2005 | EP1514552A1 Novel fused imidazole derivative |
| 03/16/2005 | EP1513870A2 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis and methods and products for detecting and/or identifying same |
| 03/16/2005 | EP1513848A2 Method of treating ischemia reperfusion injury using adenosine receptor antagonists |
| 03/16/2005 | EP1513814A1 Novel piperidine compound |
| 03/16/2005 | EP1135134B1 Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases |
| 03/15/2005 | US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency |
| 03/10/2005 | WO2005021549A1 Amorphous valganciclovir hydrochloride |
| 03/10/2005 | WO2005021548A2 Substituted 8-heteroaryl xanthines |
| 03/10/2005 | WO2005021044A2 Nanoparticles for delivery of nucleic acids and stable double-stranded rna |
| 03/10/2005 | US20050054851 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases |
| 03/10/2005 | US20050054660 8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors |
| 03/10/2005 | US20050054629 Antiproliferative agents; anticancer agents; restenosis |
| 03/10/2005 | CA2537132A1 Amorphous valganciclovir hydrochloride |
| 03/10/2005 | CA2536553A1 Substituted 8-heteroaryl xanthines |
| 03/10/2005 | CA2536191A1 Nanoparticles for delivery of nucleic acids and stable double-stranded rna |
| 03/09/2005 | EP1511750A1 Process for the preparation of famciclovir |
| 03/03/2005 | WO2005019211A2 Biaryl heterocyclic compounds and methods of making and using the same |
| 03/03/2005 | WO2004101553B1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
| 03/03/2005 | WO2004052310A3 Process and intermediates for synthesis entecavir |
| 03/03/2005 | WO2003031405A3 Methods for the synthesis of substituted purines |
| 03/03/2005 | US20050049263 Purine analogs having hsp90-inhibiting activity |
| 03/03/2005 | US20050049262 Substituted 2,5-dioxopurines, 2H-1,2,3-triazolyl[4,5-d]pyrimidines, or 1,2,5-thadiazolyl[3,4-d]pyrimidines; antiproliferative, antiinflammatory, and antiarthritic agents; psoriasis, asthma, multiple sclerosis, inflammatory bowel disease, lupus, graft versus host disease |
| 03/03/2005 | US20050049260 2-phenyl-4-pyridinyl- or -pyrimidinyl derivatives, e.g., N-Cyclopentyl-3-[2-(cyclopentylamino)-4-pyrimidinyl]-2-(4-methoxyphenyl)-pyrazolo[1,5-a]pyridin-7-amine and; especially for treatment of herpes simplex virus 1 and 2 |
| 03/03/2005 | CA2528089A1 Biaryl heterocyclic compounds and methods of making and using the same |
| 03/02/2005 | EP1509525A1 Process for preparing xanthine phosphodiesterase v inhibitors and precursors thereof |
| 03/02/2005 | EP1509524A1 Xanthine phosphodiesterase v inhibitor polymorphs |
| 03/02/2005 | EP1509497A1 Calcium receptor modulating arylalkylamines |
| 03/02/2005 | EP1509218A1 Peptide deformylase inhibitors |
| 03/02/2005 | EP1278741B1 Muscarinic agonists |
| 03/01/2005 | US6861524 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| 02/24/2005 | WO2005016528A2 6-substituted anilino purines as rtk inhibitors |
| 02/24/2005 | US20050043329 Crystalline forms of valacyclovir hydrochloride |
| 02/24/2005 | US20050043328 Such as 6-(2-hydroxy-3-chloroxybenzylamino)purine, 6-(2-hydroxy-4-chlorobenzylamino)purine; agriculture; cloning; immunostimulation |
| 02/24/2005 | US20050043317 Biaryl heterocyclic compounds and methods of making and using the same |
| 02/24/2005 | US20050043246 Acyclovir-peptide analogs |
| 02/24/2005 | CA2535620A1 6-substituted anilino purines as rtk inhibitors |
| 02/23/2005 | EP1508565A1 Process for the preparation of optically active aminoalcohols |
| 02/23/2005 | CN1585769A A2b adenosine receptor antagonists |
| 02/23/2005 | CN1585642A Pharmaceutical compositions containing 3, 4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
| 02/17/2005 | US20050038095 Azolylbenzamides and analogues and their use for treating osteoporosis |
| 02/17/2005 | US20050038046 Synergistic enhancement of cognitive ability |
| 02/17/2005 | US20050038045 A2B adenosine receptor antagonists |
| 02/17/2005 | US20050038023 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 02/17/2005 | US20050037990 Disubstituted 7,9-guanines halides as telomerase inhibitors |
| 02/16/2005 | EP1505979A1 Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles |
| 02/16/2005 | EP1414822B1 Improved synthesis of branched acyclic nucleosides |
| 02/16/2005 | CN1189467C Pharmaceutically active sulfonamide derivatives |
| 02/15/2005 | US6855821 Processes for preparing 1,3-dioxolane nucleosides |
| 02/15/2005 | US6855736 Molecular target of neurotoxicity |
| 02/10/2005 | WO2005012303A1 Metabolite of xanthine phosphodiesterase 5 inhibitor and derivatives thereof useful for treatment of erectile dysfunction |
| 02/10/2005 | WO2005012302A1 Method for the production of oh protected [4-(2.6-diamino-9h-purine-9-yl)- 1.3-dioxolane-2-yl]methanol derivatives |
| 02/10/2005 | WO2004113357A3 Nucleoside analog inhibitors of reverse transcriptase |
| 02/10/2005 | US20050033049 Heterocyclic nitrogen compounds such as 1-(5-(5-Chlorothiophen -2-yl)-isoxazol-3-ylmethyl)-1H-indole-2-carboxylic acid (1-isopropyl-piperidin-4-yl)-amide, used as anticoagulants for prophylaxis of cardiovascular disorders |
| 02/10/2005 | US20050032805 Antimicrobial biaryl compounds |
| 02/10/2005 | US20050032748 Substituted 2,5-dioxopurines, 2H-1,2,3-triazolyl[4,5-d]pyrimidines, or 1,2,5-thadiazolyl[3,4-d]pyrimidines; antiproliferative, antiinflammatory, and antiarthritic agents; psoriasis, asthma, multiple sclerosis, inflammatory bowel disease, lupus, graft versus host disease |
| 02/10/2005 | US20050032738 (E)-2'-deoxy-2'-fluoromethylidenecytidine, cytidine, vinblastine, or fluorouracil; leukemia |
| 02/10/2005 | CA2533715A1 Metabolite of xanthine phosphodiesterase 5 inhibitor and derivatives thereof useful for treatment of erectile dysfunction |
| 02/09/2005 | CN1578663A Inhibitors of histone deacetylase |
| 02/09/2005 | CN1575816A Compounds for the treatment of female sexual dysfunction |
| 02/08/2005 | CA2322900C 2-(hetero)aryl-substituted purin-6-ones as phosphodiesterase inhibitors |